# Naratriptan for the Treatment of Post Traumatic Headache Associated With Cognitive Dysfunction

> **NCT00487578** · PHASE4 · TERMINATED · sponsor: **Cady, Roger, M.D.** · enrollment: 12 (actual)

## Conditions studied

- Post Traumatic Headache

## Interventions

- **DRUG:** naratriptan HCl

## Key facts

- **NCT ID:** NCT00487578
- **Lead sponsor:** Cady, Roger, M.D.
- **Sponsor class:** INDIV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-10
- **Primary completion:** 2009-10
- **Final completion:** 2009-10
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** Terminated October 2009 (in 4th year) due to low enrollment and anticipated drug expiration November 2009.
- **Last updated:** 2013-02-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00487578

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00487578, "Naratriptan for the Treatment of Post Traumatic Headache Associated With Cognitive Dysfunction". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00487578. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*